Last reviewed · How we verify

NCT06971809: Resilience

Pain Resilience for Low Back Pain.

ENROLLING BY INVITATION NA Last updated 14 May 2025
What this trial tests

NA trial testing Pain resilience in Chronic Low Back Pain (CLBP) in 30 participants. Enrolling by invitation.

Timeline
1 October 2024
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorIntegrative Pain Science Institute
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date1 October 2024
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Integrative Pain Science Institute

Who can join

Adults 18 to 85, any sex, with Chronic Low Back Pain (CLBP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic pain affects about 20% of adults in the U.S. and can lead to serious personal, social, and economic challenges. It is often treated with medications, including opioids, which carry risks of dependence. While pain education (PE) helps people better understand their pain and may reduce symptoms, it generally has only modest effects when used alone. The purpose of this study is to explore whether combining pain education with other treatments-such as physical therapy, cognitive behavioral techniques, and healthy lifestyle strategies-in a multi-modal resilience approach can offer greater benefits. The study aims to answer the following question: Can a combined, whole-person approach improve outcomes in people with chronic pain more effectively than pain education alone?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Low Back Pain (CLBP)

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06971809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing